Background-Prescription and use of long term oxygen treatment were audited in a large group of patients after more than five years of use of the guidelines for its prescription. Methods-Patients with a concentrator were interviewed at home with a structured questionnaire in three family health service authorities in East London. Stable oxygen saturation (Sao,) breathing air and oxygen, forced expiratory volume in one second (FEV,) 
that long term oxygen treatment improved survival in patients with hypoxic chronic obstructive lung disease, the Department of Health produced guidelines for the prescription of oxygen concentrators by general practitioners. The indications for prescribing long term oxygen are described in the Appendix. Current guidelines recommend that all patients should be assessed when their condition is stable by a respiratory physician with verification of results after three weeks, before long term oxygen treatment is recommended.3'The guidelines also include recommendations for follow up, including a statement on the requirement for "regular monitoring in the home by appropriately trained nurses or lung function technicians to ensure that treatment is achieving optimum results." There is, however, currently no provision for formal organisation of this domiciliary follow up.
Earlier surveys in England of small numbers of patients (ranging from 61 to 82) have each described a different aspect of concentrator prescription and use." Initial prescription of oxygen did not always adhere to the guidelines and was often inappropriate, particularly when the prescription was initiated by a general practitioner without previous specialist respiratory assessment.45 In both the United Kingdom6 and Europe7 long term oxygen treatment has had problems, either because of inappropriate instructions or because of poor compliance. As the guidelines for prescribing long term oxygen have now been in use for more than five years it is useful to audit the current situation.
We assessed both prescription and use of long term oxygen in a large group of patients. The most important issues addressed were adherence to the guidelines for prescription, communication between respiratory physicians and general practitioners, and the provision of follow up, which have not previously been studied; patient compliance and problems with the use of long term oxygen; and the characteristics of patients who, at domiciliary reassessment, did not-meet the criteria for oxygen treatment.
Methods
All patients recorded as having a concentrator on 1 January 1991 in the three family health (5) 5 (3) 6 (3) 2 (1) breathless on talking. However, 55% (97) of patients said that they were able to go out (other than for medical visits to their general practitioner or to hospital), including 47% (65/137) who said that they were breathless walking around at home. Only 9% (16) In the 173 patients in whom it was possible to measure Sao, after 20 minutes of breathing air (three felt too unwell without oxygen) the mean (SD) Sao2 was 88&9% (5 8%). One hundred and six (61%) patients had an Sao2 of 91 % or below when breathing air at reassessment and were considered to fulfil the guidelines for long term oxygen at follow up.
The mean Sao2 after 20 minutes of breathing oxygen delivered by the concentrator measured in 170 patients was 94A4% (3A4%).
Sao, was significantly increased by using the concentrator compared with breathing air (p < 0 005; 95% confidence interval of difference 5-1% to 6-3%). However, 29 patients had an undercorrected Sao2 of less than 92% when using their concentrator to deliver oxygen even though 28 of these patients were under supervision as outpatients.
PRESCRIPTION AND USE
The figure (A) The patients with problems were no less compliant with taking treatment and had adequately corrected oxygen saturations with oxygen, the mean Sao2 using the concentrator being 94-7% (2'9%).
Thirty four patients were aged 75 and over; 76% (26) of these were breathless walking round at home and 47% (16) were able to go out. The median hours of daily use (14 (1-24)) was significantly less in those of 75 and older than in those under 75 (16 (0-24)) (p = 0 005), but the proportion with problems with the treatment was not significantly different between the two age groups (21% (7/34) in those of 75 and over and 20% (28/142) in the younger patients). REVIEW At follow up 67 patients had an Sao, above 91 % when breathing air. These patients were studied in further detail to evaluate whether they fulfilled the criteria for long term oxygen treatment at the time of initial prescription. Information was available on 58 (87%) of these patients, from case notes for 55 patients, and from the general practitioner questionnaire for the three patients who were under the care of their family doctor alone. Table 2 shows the characteristics ofthese patients.
All 13 of the patients with nocturnal hypoventilation had been fully assessed for long term oxygen, including by overnight sleep studies. Only one of each of the two patients with bronchiectasis and heart failure had been formally assessed and met the criteria for its prescription. Of the 41 patients with chronic obstructive lung disease, 30 were prescribed oxygen on the instructions of a respiratory physician. However, in seven of these patients assessment was performed during an exacerbation when the patient's condition was not stable, and two patients were not assessed formally. The mean Pao2 at the time of prescription in the 23 of the 30 in whom it was available was 7-6 (1-4) kPa and 11 patients had a Pao2 above 7-3 kPa. Twenty nine of the 30 patients in whom oxygen treatment was initiated by a respiratory physician were followed up in outpatient clinics where spirometry was performed in 21 patients and oximetry or measurement of arterial blood gas concentrations in 16. Of the 11 patients in whom treatment was initiated by their general practitioner, nine were already being followed up in respiratory outpatient clinics. In five of them the mean Pao, recorded in the notes was 9-8 (2.9) kPa. Therefore only 12 out of the 41 patients with chronic obstructive lung disease who had a follow up Sao2 above 91% when breathing air met the single criterion of a Pao2 of less than 7-3 kPa at assessment for prescribing long term oxygen treatment.
The prescription of oxygen was appropriate in only 27 out of 58 patients who had a follow up Sao, above 91% when breathing air (notes could not be traced for the remaining nine patients out of a total of 67). Overall, with the combination of screening oximetric results and review of Pao, at the time of the initial prescription of oxygen in those patients who did not meet the screening requirements, 133 out of a total of 176 patients met simplified criteria for prescription of long term oxygen treatment.
Discussion
The rate of prescription of 16 per 100 000 population in our study of patients prescribed long term oxygen in East London is consistent with the national rate in the United Kingdom of 8000 concentrators per 50 million population.9 In our study the initial prescription of oxygen was by a respiratory physician in over 80% of patients, most of whom had chronic obstructive lung disease. In 75% of cases the general practitioner knew that a respiratory assessment had been performed, although the results were available to them in under a third of cases. At reassessment, 76% of patients either continued to be hypoxaemic or had fulfilled the criteria for being prescribed oxygen. The median duration of installation was 19 months and 83% of patients were using oxygen for 15 hours or more. A fifth of patients admitted to still smoking. There were no significant differences in either prescription or use of oxygen between the three family health service authorities, and the larger number of concentrators prescribed in City and East London probably reflects local referral patterns.
The proportion of patients in whom formal respiratory assessments were performed compares favourably with previous surveys. In earlier studies fewer than 60% of prescriptions for long term oxygen were on the recommendation of a respiratory physician and only 43% to 63% of patients fulfilled the Department of Health criteria." This improvement probably reflects both local initiatives and increasingly widespread awareness of the guidelines since their introduction in 1985. Our results from East London compare favourably with results from Sweden, where 88% of patients were seen by a respiratory physician and 86% had arterial blood gases measured before oxygen was prescribed.10 Although general practitioners are responsible for the prescription of long term oxygen in England and Wales, our results show that they are often not informed of the results of respiratory assessments for such treatment. This situation could be improved by the use of a standardised form as a method of communication. Continued communication between respiratory physicians and general practitioners is very important in maintaining an efficient home oxygen service.
Arterial blood gas measurements are required at the time of prescription of oxygen, both to assess hypoxaemia accurately and to assess hypercapnia, but oximetry has a valuable and increasing role in screening patients for such treatment and detecting undercorrection of oxygen saturation by the concentrator.8 1' We also used it to identify patients who were not hypoxaemic at follow up. A fifth of the patients with an oxygen saturation above 91% while breathing air at reassessment had been prescribed oxygen for nocturnal hypoventilation, in which daytime oxygen saturation could have been normal. Long term overnight oxygen treatment in patients with normal daytime Pao2 and sleep desaturation corrects arterial oxygen saturation and reduces pulmonary artery pressure, but no evidence exists that mortality is reduced.'2 However, nocturnal oxygen treatment delivered by concentrator is widely used as a treatment for nocturnal hypoventilation,"3 and nocturnal hypoventilation documented in sleep studies could be considered to be a further indication for installing a concentrator in the Department of Health guidelines.
Information available on the 41 patients with chronic obstructive lung disease taking oxygen who had an oxygen saturation above 91 % while breathing air at reassessment showed that the criteria for prescribing oxygen were met in only 12 cases. The effect of stopping oxygen treatment in such patients, who are hypoxaemic at the time of prescription but improve with long term treatment and are no longer hypoxaemic, is unknown. ' The unit costs of oxygen delivered by a concentrator have fallen relative to the use of cylinders, and long term oxygen treatment for 16 hours a day currently costs £500 annually compared with £6000 when oxygen is delivered by cylinders. '5 In the light of changes in both costs and clinical practice of prescribing long term oxygen treatment over seven years the guidelines may need to be reviewed. There remains far more underprescription of concentrators than inappropriate prescription.'6 This has implications for hypoxaemic patients with chronic obstructive lung disease who may be denied the possibility of benefit from long term oxygen and also has financial implications for the National Health Service. Nearly one million oxygen cylinders were supplied in England and Wales in 1989,"7 and many patients are probably still using oxygen cylinders. As oxygen taken for more than eight hours a day is more cheaply provided by oxygen concentrators, some of the costs of making long term oxygen treatment more widely available could be absorbed by rationalising the prescription of oxygen cylinders.
In conclusion, a high proportion of prescriptions conformed with the guidelines for prescription of long term oxygen. Most patients complied with treatment. However, increased communication is required between hospital doctors and general practitioners. Patients need regular reassessment to ensure that hypoxaemia is optimally corrected and that oxygen has been appropriately prescribed. Reassessment should be a condition for the continuation of treatment to maximise benefit and minimise problems. This could initially be achieved by domiciliary screening by oximetry to select the patients who would require arterial blood gas assessment and outpatient review. A formal organised home respiratory care programme is required to ensure that patients are treated optimally.
